Melissa Raspa1, Anne C Wheeler2, Catharine Riley3. 1. RTI International, Research Triangle Park, North Carolina; and mraspa@rti.org. 2. RTI International, Research Triangle Park, North Carolina; and. 3. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
OBJECTIVES: The purpose of this systematic literature review is to describe what is known about fragile X syndrome (FXS) and to identify research gaps. The results can be used to help inform future public health research and provide pediatricians with up-to-date information about the implications of the condition for individuals and their families. METHODS: An electronic literature search was conducted, guided by a variety of key words. The search focused on 4 areas of both clinical and public health importance: (1) the full mutation phenotype, (2) developmental trajectories across the life span, (3) available interventions and treatments, and (4) impact on the family. A total of 661 articles were examined and 203 were included in the review. RESULTS: The information is presented in the following categories: developmental profile (cognition, language, functional skills, and transition to adulthood), social-emotional profile (cooccurring psychiatric conditions and behavior problems), medical profile (physical features, seizures, sleep, health problems, and physiologic features), treatment and interventions (educational/behavioral, allied health services, and pharmacologic), and impact on the family (family environment and financial impact). Research gaps also are presented. CONCLUSIONS: The identification and treatment of FXS remains an important public health and clinical concern. The information presented in this article provides a more robust understanding of FXS and the impact of this complex condition for pediatricians. Despite a wealth of information about the condition, much work remains to fully support affected individuals and their families.
OBJECTIVES: The purpose of this systematic literature review is to describe what is known about fragile X syndrome (FXS) and to identify research gaps. The results can be used to help inform future public health research and provide pediatricians with up-to-date information about the implications of the condition for individuals and their families. METHODS: An electronic literature search was conducted, guided by a variety of key words. The search focused on 4 areas of both clinical and public health importance: (1) the full mutation phenotype, (2) developmental trajectories across the life span, (3) available interventions and treatments, and (4) impact on the family. A total of 661 articles were examined and 203 were included in the review. RESULTS: The information is presented in the following categories: developmental profile (cognition, language, functional skills, and transition to adulthood), social-emotional profile (cooccurring psychiatric conditions and behavior problems), medical profile (physical features, seizures, sleep, health problems, and physiologic features), treatment and interventions (educational/behavioral, allied health services, and pharmacologic), and impact on the family (family environment and financial impact). Research gaps also are presented. CONCLUSIONS: The identification and treatment of FXS remains an important public health and clinical concern. The information presented in this article provides a more robust understanding of FXS and the impact of this complex condition for pediatricians. Despite a wealth of information about the condition, much work remains to fully support affected individuals and their families.
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Donald B Bailey; Melissa Raspa; Ellen Bishop; Murrey Olmsted; Usha G Mallya; Elizabeth Berry-Kravis Journal: J Dev Behav Pediatr Date: 2012-01 Impact factor: 2.225
Authors: G S Fisch; R Simensen; J Tarleton; M Chalifoux; J J Holden; N Carpenter; P N Howard-Peebles; A Maddalena Journal: Am J Med Genet Date: 1996-08-09
Authors: Jane E Roberts; Anna C J Long; Lindsay M McCary; Amy N Quady; Bonnie S Rose; Dean Widrick; Grace Baranek Journal: J Pediatr Psychol Date: 2012-11-11
Authors: Heather Cody Hazlett; Michele D Poe; Amy A Lightbody; Guido Gerig; James R Macfall; Allison K Ross; James Provenzale; Arianna Martin; Allan L Reiss; Joseph Piven Journal: J Neurodev Disord Date: 2009-03 Impact factor: 4.025
Authors: Lauren A McCormack; Amanda Wylie; Rebecca Moultrie; Robert D Furberg; Anne C Wheeler; Katherine Treiman; Donald B Bailey; Melissa Raspa Journal: PLoS One Date: 2019-10-23 Impact factor: 3.240
Authors: Sara M Andrews; Melissa Raspa; Anne Edwards; Rebecca Moultrie; Lauren Turner-Brown; Laura Wagner; Alexandra Alvarez Rivas; Mary Katherine Frisch; Anne C Wheeler Journal: J Am Med Inform Assoc Date: 2020-03-01 Impact factor: 4.497
Authors: Thuy Quynh N Do; Catharine Riley; Pangaja Paramsothy; Lijing Ouyang; Julie Bolen; Scott D Grosse Journal: Am J Intellect Dev Disabil Date: 2020-03
Authors: Emma K Baker; Sheena Arora; David J Amor; Perrin Date; Meagan Cross; James O'Brien; Chloe Simons; Carolyn Rogers; Stephen Goodall; Jennie Slee; Chris Cahir; David E Godler Journal: J Autism Dev Disord Date: 2021-07-22